Hepatocyte growth factor (HGF) in patients with acute brucellosis

Scandinavian Journal of Infectious Diseases

Volumn 36, Issue 2, 2004, Pages 109-113

  Ozden, Mehmet ^a   Kalkan, Ahmet ^a   Demirdag, Kutbettin ^a   Kilic, S Sirri ^a   Denk, Affan ^a   Yuce, Pinar ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DOXYCYCLINE; RIFAMPICIN; SCATTER FACTOR;

ADULT; ARTICLE; BRUCELLOSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VOLUNTEER;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; BRUCELLOSIS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 1542300084     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410019110     Document Type: Article

References (23)

1. Young EJ. An overview of human brucellosis. Clin Infect Dis 1995; 21: 283-9.
2. Corbel MJ. Brucellosis and overview. Emerg Infect Dis 1997; 3: 213-21.
3. Young EJ. Brucella species. In: Mandell GL, Bennet JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 5th edn. New York: Churchill Livingstone; 2000. p. 2386-91.
4. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Miyazaki H. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988; 81: 414-9.
5. Naka D, Ishii T, Yoshiyama Y, Miyazawa K, Hara H, Hishida T, Kidamura N. Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer. J Biol Chem 1992; 267: 20114-9.
6. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450-9.
7. Tajima H, Matsumoto K, Nakamura T. Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species. Exp Cell Res 1992; 202: 423-31.
8. Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991; 67: 901-8.
9. Boros P, Miller CM. Hepatocyte growth factor; a multifunctional cytokine. Lancet 1995; 345: 293-5.
10. Kono S, Nagaike M, Matsumoto K, Nakamura T. Marked induction of hepatocyte growth factor mRNA in intact kidney and spleen in response to injury of distant organs. Biochem Biophsy Res Commun 1992; 186: 991-8.
11. Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T. Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology 1995; 21: 106-12.
12. Yanagita K, Matsumoto K, Sekiguchi K, Ishibashi H, Niho Y, Nakamura T. Hepatocyte growth factor may act as a pulmonotrophic factor on lung regeneration after acute lung injury. J Biol Chem 1993; 268: 21212-7.
13. Vargas GA, Hoeflich A, Jehle PM. Hepatocyte growth factor in renal failure: promise and reality. Kidney Int 2000; 57: 1426-36.
14. Nayeri F, Nilsson I, Brudin L, Fryden A, Söderström C, Forsberg P. High serum hepatocyte growth factor levels in the acute stage of community-acquired infectious diseases. Scand J Infect Dis 2002; 34: 127-30.
15. Sakon M, Kita Y, Yoshida T, Umeshita K, Gotoh M, Kanai T, et al. Plasma hepatocyte growth factor levels are increased in systemic inflammatory response syndrome. Surg Today 1996; 26: 236-41.
16. Maeda J, Ueki N, Hada T, Higashino K. Elevated serum hepatocyte growth factor/scatter factor levels in inflammatory lung disease. Am J Respir Crit Care Med 1995; 152: 1587-91.
17. Nayeri F, Nilsson I, Hagberg L, Brudin L, Roberg M, Söderström C, Forsberg P. Hepatocyte growth factor levels in cerebrospinal fluid: a comparison between acute bacterial and non-bacterial meningitis. J Infect Dis 2000; 181: 2092-4.
18. Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem 1996; 119: 591-600.
19. Nayeri F, Brudin L, Darelid J, Nilsson I, Fryden A, Söderström C, Forsberg P. Hepatocyte growth factor may act as an early therapeutic predictor in pneumonia. Scand J Infect Dis 2002; 34: 500-4.
20. Nayeri F, Nilsson I, Skude G, Brudin L, Söderström C. Hepatocyte growth factor (HGF) in patients with pneumonia: a comparison between survivors and non-survivors. Scand J Infect Dis 1998; 30: 405-9.
21. Dabdoob WA, Abdulla ZA. A panel of 8 tests in the serodiagnosis and immunological evaluation of acute brucellosis. East Mediterr Health J 2000; 6: 304-12.
22. al-Kassab AS, Nur MA, Malik JM. Evaluation of serum C-reactive protein in the diagnosis of arthritic and non-arthritic brucellosis. J Trop Med Hyg 1991; 94: 92-6.
23. Navarro JM, Mendoza J, Leiva J, Rodriguez-Contreras R, de la Rosa M. C-reactive protein as a prognostic indicator in acute brucellosis. Diagn Microbiol Infect Dis 1990; 13: 269-70.